Research

Hormonal

GLP-1RAs exert their therapeutic effects through complex intracellular signaling pathways, specifically activating ERK1/2, AMPK, cAMP, MAPK, and PKC, which regulate insulin secretion, cell proliferation, and inflammation.

The effectiveness of GLP-1 medications is driven by their ability to activate specific cellular pathways (ERK1/2, AMPK, cAMP, MAPK, PKC). These pathways control insulin release, cell growth, and inflammation, which is why these drugs work for both diabetes and potentially other conditions like cancer or cardiovascular disease.

GoodSupportsHIGH confidence
The secret of GLP-1RAs’ medicinal efficacy is their complex interplay with several cellular signaling pathways... Beta cell insulin production is enhanced by activation of pathways such as ERK1/2 and AMPK... GLP-1 influences a complex network of signaling cascades, and recent investigations have shown that the MAPK and PKC pathways are also involved.
Tohada M. AL‐Noshokaty et al. · Toxicology Reports · 2025

Why this rating

The paper reviews multiple studies linking these pathways to GLP-1 effects.

Source

Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential

Tohada M. AL‐Noshokaty et al. · Toxicology Reports · 2025

DOI 10.1016/j.toxrep.2025.101895

narrative_reviewCited 22×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →